Cancer ResearchSilica Nanoparticles Destroy Aggressive Prostate Cancer and Boost Immunity in Mice
Researchers at Weill Cornell Medicine tested ultrasmall silica nanoparticles called C' dots in mice with aggressive prostate cancer. The particles attacked tumors in two ways: triggering ferroptosis, a form of oxidative cell self-destruction, and converting the tumor microenvironment from immune-cold to immune-hot. When combined with immunotherapy, the treatment produced complete remissions in multiple mice. Originally designed for medical imaging, C' dots have already entered late-stage clinical trials for image-guided surgery, giving them a credibility advantage over purely experimental agents. The study, published in Cancer Research, suggests this dual-action approach could represent a new clinical paradigm for treating one of the most common and deadly cancers in men.
